Cycurion Registers Resale of 25.8M Shares, Including $49.7M Remaining from Equity Line

summarizeSummary

Cycurion filed an S-1 to register the resale of 25.8 million shares, including those from a $60 million equity line and a recent acquisition, representing over 225% of current outstanding shares and creating substantial market overhang.

check_boxKey Events · Financing and Capital Events · CYCU

• Massive Resale Registration

  Registers up to 25,888,888 shares for resale by selling stockholders, including 25,000,000 shares from an Equity Purchase Agreement (ELOC) with Yield Point NY LLC and 888,888 shares from the Secuvant acquisition.

• Significant Potential Dilution

  The registered shares represent approximately 225.6% of the current 11,472,588 outstanding common shares, indicating a substantial market overhang.

• Equity Line of Credit Details

  The company has an existing $60 million ELOC with Yield Point, with $49.7 million remaining. Shares under this program are sold at a 10% discount to the lowest daily volume-weighted average price (VWAP), which is highly dilutive.

• Secuvant Acquisition Shares

  888,888 shares of Series I Convertible Preferred Stock, convertible into common stock at $2.25 per share, are also registered for resale.

auto_awesomeAnalysis · CYCU · Technology

This S-1 filing registers the resale of a substantial number of shares, representing approximately 225.6% of current outstanding common stock. This includes shares from an existing $60 million equity line of credit (ELOC), of which $49.7 million remains available for future sales by the company to Yield Point at a 10% discount to market price. Additionally, shares issued for the recent Secuvant acquisition are also registered for resale. The significant potential dilution and market overhang are critical for a company already facing "going concern" doubts and trading below Nasdaq's minimum bid price. While enabling capital access, the terms are highly unfavorable for existing shareholders.